Richard Keefe
Richard Keefe
Professor of Psychiatry and Behavioral Sciences
Verified email at duke.edu
Title
Cited by
Cited by
Year
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman, TS Stroup, JP McEvoy, MS Swartz, RA Rosenheck, ...
New England journal of medicine 353 (12), 1209-1223, 2005
60852005
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
KH Nuechterlein, MF Green, RS Kern, LE Baade, DM Barch, JD Cohen, ...
American Journal of Psychiatry 165 (2), 203-213, 2008
15652008
Persistent cannabis users show neuropsychological decline from childhood to midlife
MH Meier, A Caspi, A Ambler, HL Harrington, R Houts, RSE Keefe, ...
Proceedings of the National Academy of Sciences 109 (40), E2657-E2664, 2012
12822012
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ...
Archives of general psychiatry 64 (6), 633-647, 2007
11032007
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
JP McEvoy, JA Lieberman, TS Stroup, SM Davis, HY Meltzer, ...
American Journal of Psychiatry 163 (4), 600-610, 2006
10212006
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
RSE Keefe, TE Goldberg, PD Harvey, JM Gold, MP Poe, L Coughenour
Schizophrenia research 68 (2-3), 283-297, 2004
9992004
The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis
RSE Keefe, SG Silva, DO Perkins, JA Lieberman
Schizophrenia bulletin 25 (2), 201-222, 1999
9031999
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
MF Green, KH Nuechterlein, JM Gold, DM Barch, J Cohen, S Essock, ...
Biological psychiatry 56 (5), 301-307, 2004
8952004
Antipsychotic drug effects on brain morphology in first-episode psychosis
JA Lieberman, GD Tollefson, C Charles, R Zipursky, T Sharma, RS Kahn, ...
Archives of general psychiatry 62 (4), 361-370, 2005
8442005
Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
PD Harvey, RSE Keefe
American Journal of Psychiatry 158 (2), 176-184, 2001
7622001
Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators; Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman
N Engl J Med 353, 1209-1223, 2005
5622005
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization
RS Kern, KH Nuechterlein, MF Green, LE Baade, WS Fenton, JM Gold, ...
American Journal of Psychiatry 165 (2), 214-220, 2008
5282008
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic
TS Stroup, JA Lieberman, JP McEvoy, MS Swartz, SM Davis, ...
American Journal of Psychiatry 163 (4), 611-622, 2006
5142006
Barriers to employment for people with schizophrenia
R Rosenheck, D Leslie, R Keefe, J McEvoy, M Swartz, D Perkins, ...
American Journal of Psychiatry 163 (3), 411-417, 2006
5072006
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
RW Buchanan, M Davis, D Goff, MF Green, RSE Keefe, AC Leon, ...
Schizophrenia bulletin 31 (1), 5-19, 2005
4932005
A genome-wide investigation of SNPs and CNVs in schizophrenia
AC Need, D Ge, ME Weale, J Maia, S Feng, EL Heinzen, KV Shianna, ...
PLoS genetics 5 (2), 2009
4902009
Baseline neurocognitive deficits in the CATIE schizophrenia trial
RSE Keefe, RM Bilder, PD Harvey, SM Davis, BW Palmer, JM Gold, ...
Neuropsychopharmacology 31 (9), 2033-2046, 2006
4902006
Schizophrenia is a cognitive illness: time for a change in focus
RS Kahn, RSE Keefe
JAMA psychiatry 70 (10), 1107-1112, 2013
4792013
Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol
JA Lieberman, G Tollefson, M Tohen, AI Green, RE Gur, R Kahn, ...
American Journal of Psychiatry 160 (8), 1396-1404, 2003
4602003
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study
A Reichenberg, A Caspi, HL Harrington, R Houts, RSE Keefe, RM Murray, ...
American Journal of Psychiatry 167 (2), 160-169, 2010
4282010
The system can't perform the operation now. Try again later.
Articles 1–20